Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Midostaurin

Midostaurin (PKC412; CGP 41251) is an orally active, reversible multi-targeted protein kinase inhibitor. Midostaurin inhibits PKCα/β/γ, Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFRβ and VEGFR1/2 with IC50s ranging from 22-500 nM[1][2]. Midostaurin also upregulates endothelial nitric oxide synthase (eNOS) gene expression. Midostaurin shows powerful anticancer effects[3].

Product Specifications

CAS Number

[120685-11-2]

Product Name Alternative

PKC412; CGP 41251

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; c-Kit; NO Synthase; PKC; VEGFR

Type

Reference compound

Related Pathways

Apoptosis; Epigenetics; Immunology/Inflammation; Protein Tyrosine Kinase/RTK; TGF-beta/Smad

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/PKC412.html

Purity

99.91

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=CC=C1)N(C)[C@H]2[C@@H](OC)[C@@]3(C)N(C4=C5C=CC=C4)C6=C5C7=C(C(NC7)=O)C8=C6N(C9=CC=CC=C98)[C@@](O3)([H])C2

Molecular Formula

C35H30N4O4

Molecular Weight

570.64

Precautions

H302, H315, H319, H335

References & Citations

[1]Fabbro D, et al. PKC412--a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug Des. 2000 Feb;15 (1) :17-28.|[2]Gleixner KV, et al. Synergistic growth-inhibitory effects of Midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V. Haematologica. 2013 Sep;98 (9) :1450-7.|[3]Chi HT, et al. ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412. Biochem Biophys Res Commun. 2012 Dec 7;429 (1-2) :87-92.|[4]Kwan R, et al. PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding. Hepatology. 2015 Dec;62 (6) :1858-69.|[5]Fabbro D, et al. Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agent. Pharmacol Ther. 1999 May-Jun;82 (2-3) :293-301.|[6]Huige Li, et al. Midostaurin upregulates eNOS gene expression and preserves eNOS function in the microcirculation of the mouse. Nitric Oxide. 2005 Jun;12 (4) :231-6.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

ENOS; PKCα; PKCβ; PKCγ; PKCδ; PKCε; PKCζ; PKCη

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Tissue FFPE Sections, Kidney
CS801233 5x 5 µm

Tissue FFPE Sections, Kidney

Ask
View Details
PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)
MBS2041949-01 0.1 mL

PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)

Ask
View Details
PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)
MBS2041949-02 0.2 mL

PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)

Ask
View Details
PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)
MBS2041949-03 0.5 mL

PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)

Ask
View Details
PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)
MBS2041949-04 1 mL

PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)

Ask
View Details
PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)
MBS2041949-05 5 mL

PE-Linked Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)

Ask
View Details